News & Updates
Showing Pharmacy articles
Showing

Fewer CV events after COVID-19 vaccine-related myocarditis
In a nationwide French cohort study, myocarditis attributed to COVID-19 mRNA vaccination causes fewer cardiovascular (CV) events at 18 months of follow-up than that attributed to SARS-CoV-2 infection or myocarditis of conventional aetiologies.
Fewer CV events after COVID-19 vaccine-related myocarditis
13 Sep 2024
RSV a hidden threat in older adults: Vaccination key to preventing severe outcomes
Respiratory syncytial virus (RSV) is often associated with severe illness in young children, but its impact on older adults is a growing concern. In older adults, RSV can lead to serious consequences, including hospitalization and death. [BMC Infect Dis 2017;20;17:785] Unlike other viruses, immunity to RSV infection is incomplete and short-lived, making reinfection common throughout life. [Respiratory Syncytial Virus. www.ncbi.nlm.nih.gov/books/NBK442240/] Despite this, RSV in adults remains underrecognized and underestimated. Addressing this overlooked risk requires a focused approach, with vaccination playing a crucial role in preventing severe RSV-related complications in older populations.
RSV a hidden threat in older adults: Vaccination key to preventing severe outcomes
13 Sep 2024
LNG-IUS use ups risk of depression
Use of a levonorgestrel-releasing intrauterine system (LNG-IUS) appears to increase the risk of incident depression, defined as initiation of an antidepressant or receipt of a depression diagnosis, in a dose-dependent manner, suggests a study.






